Literature DB >> 16272211

Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery.

Sorin J Brener1, Bruce W Lytle, Ivan P Casserly, Stephen G Ellis, Eric J Topol, Michael S Lauer.   

Abstract

AIMS: The optimal revascularization strategy in patients with symptomatic multivessel coronary artery disease (CAD) and previous coronary artery bypass grafting (CABG) remains unknown. METHODS AND
RESULTS: We evaluated all patients with previous CABG undergoing isolated, non-emergency multivessel revascularization between 1 January 1995 and 31 December 2000. The analysis concentrated on the independent predictors of the revascularization method, as well as on long-term mortality and its predictors, after calculating a propensity score for the method of revascularization. There were 2191 patients (1487 with reoperation and 704 with percutaneous coronary intervention, PCI) in the study. The most important factors in choosing reoperation were presence of more diseased or occluded grafts, previous infarction, lower ejection fraction (EF), longer interval from first CABG, and more total occlusions of native arteries, as well as absence of a patent mammary graft. The distribution of the propensity score was skewed towards the two extremes. At 5 years, the unadjusted cumulative survival was 79.5% for CABG and 75.3% for PCI, P=0.008. After adjustment for the propensity score for PCI vs. CABG, PCI was associated with a hazard ratio of 1.47 (0.94-2.28), P=0.09. The most powerful predictors of mortality were higher age and lower EF.
CONCLUSION: The choice of the revascularization method in patients with previous CABG is dictated mostly by anatomical considerations and less by clinical characteristics. In contrast, clinical characteristics predominantly affect long-term outcome, whereas the method of revascularization has a limited effect. A randomized clinical trial addressing this important segment of the population with ischaemic heart disease is warranted.

Entities:  

Mesh:

Year:  2005        PMID: 16272211     DOI: 10.1093/eurheartj/ehi646

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

Review 1.  Secondary revascularization after CABG surgery.

Authors:  Javier Escaned
Journal:  Nat Rev Cardiol       Date:  2012-07-10       Impact factor: 32.419

Review 2.  Multidetector CT and coronary artery bypass grafts.

Authors:  F Crusco; A Antoniella; V Papa; D Di Lazzaro; T Ragni; A Giovagnoni
Journal:  Radiol Med       Date:  2007-12-13       Impact factor: 3.469

Review 3.  Contemporary coronary artery bypass graft surgery and subsequent percutaneous revascularization.

Authors:  Frans J Beerkens; Bimmer E Claessen; Marielle Mahan; Mario F L Gaudino; Derrick Y Tam; José P S Henriques; Roxana Mehran; George D Dangas
Journal:  Nat Rev Cardiol       Date:  2021-10-05       Impact factor: 32.419

4.  Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: a population-based study in Olmsted County, Minnesota.

Authors:  Thomas J Kiernan; Barry A Boilson; Gurpreet S Sandhu; Ryan J Lennon; Veronique L Roger; Gregory W Barsness; Amir Lerman; Charanjit S Rihal; Robert D Simari
Journal:  Coron Artery Dis       Date:  2009-03       Impact factor: 1.439

5.  A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure.

Authors:  Ali Ahmed; Faiez Zannad; Thomas E Love; Jose Tallaj; Mihai Gheorghiade; Olaniyi James Ekundayo; Bertram Pitt
Journal:  Eur Heart J       Date:  2007-06       Impact factor: 29.983

Review 6.  Management and Prevention of Saphenous Vein Graft Failure: A Review.

Authors:  Peter McKavanagh; Bobby Yanagawa; George Zawadowski; Asim Cheema
Journal:  Cardiol Ther       Date:  2017-07-26

7.  Coronary Angiography Characteristics of Symptomatic Patients with Prior Coronary Artery Bypass Graft: A Descriptive Study.

Authors:  Xiaolong Ma; Pengfei Chen; Yicheng Zhao; Caiwu Zeng; Meng Xin; Qing Ye; Jiangang Wang
Journal:  Biomed Res Int       Date:  2019-11-11       Impact factor: 3.411

Review 8.  Comparing mortality and myocardial infarction between coronary artery bypass grafting and drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.

Authors:  Xiaolong Qi; Mingxin Xu; Haitao Yang; Lin Zhou; Yu Mao; Haoming Song; Quan Li; Changqing Yang
Journal:  Arch Med Sci       Date:  2014-06-27       Impact factor: 3.318

9.  Trends in Reoperative Coronary Artery Bypass Graft Surgery for Older Adults in the United States, 1998 to 2017.

Authors:  Makoto Mori; Yun Wang; Karthik Murugiah; Rohan Khera; Aakriti Gupta; Prashanth Vallabhajosyula; Frederick A Masoudi; Arnar Geirsson; Harlan M Krumholz
Journal:  J Am Heart Assoc       Date:  2020-10-13       Impact factor: 5.501

Review 10.  Advances in the Post-coronary Artery Bypass Graft Management of Occlusive Coronary Artery Disease.

Authors:  Mohammed Shamim Rahman; Ruben de Winter; Alex Nap; Paul Knaapen
Journal:  Interv Cardiol       Date:  2021-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.